10h
GlobalData on MSNHealx doses first subject in Phase II neurofibromatosis type 1 therapy trialHealx has dosed the first subject in the open-label Phase II INSPIRE-NF1 trial to assess the efficacy and safety of HLX-1502 ...
Forget sneakers or cleats and put on those boogie shoes, as new research from Northeastern University finds that dancing can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results